NCT01413178
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,610 public trials
494 recruiting studies
Multiple Myeloma trial results
NCT01212952
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01497093
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT01087008
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hospital Universitari Germans Trias I Pujol Badalona, Spain
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
- Hospital del Mar Barcelona, Spain
- Hospital Vall d'Hebrón Barcelona, Spain
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
NCT00006890
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
- Burnaby Hospital Regional Cancer Centre Burnaby, British Columbia, Canada
NCT00002678
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- St. Mary's/Duluth Clinic Health System Duluth, Minnesota, United States
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
NCT01010217
- Conditions
- Anemia, Anemia, Aplastic, Blood Protein Disorders, +38 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT02492750
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
NCT01023308
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Anaheim, California, United States
- Novartis Investigative Site Concord, California, United States
- Novartis Investigative Site Los Angeles, California, United States